Targepeutics Overview
- Year Founded
-
1997
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Seed
- Investors
-
3
Targepeutics General Information
Description
Operator of a biopharmaceutical company intended to develop molecularly targeted therapeutics to fight cancer and other diseases. The company's services include drug discovery, research and development, and clinical design, enabling medical industry players to treat and destroy cancer cells with minimal normal cell damage.
Contact Information
Website
www.targepeutics.comCorporate Office
- 1214 Research Boulevard
- Suite 1011
- Hummelstown, PA 17036
- United States
Corporate Office
- 1214 Research Boulevard
- Suite 1011
- Hummelstown, PA 17036
- United States
Targepeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 24-Jul-2025 | Completed | Clinical Trials - Phase 3 | |||
| 2. Accelerator/Incubator | 01-Mar-2023 | Completed | Clinical Trials - Phase 3 | |||
| 1. Grant | 01-Jan-2022 | $275K | Completed | Clinical Trials - Phase 3 |
Targepeutics Patents
Targepeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026050761-A1 | Noninvasive tracking of a targeted toxin | Pending | 30-Aug-2024 | ||
| JP-2026536310-A | Hydrogel composition for the treatment of malignant glioma | Pending | 12-Oct-2023 | ||
| AU-2024357719-A1 | Hydrogel compositions for treatment of malignant gliomas | Pending | 12-Oct-2023 | ||
| EP-4791435-A1 | Hydrogel compositions for treatment of malignant gliomas | Pending | 12-Oct-2023 | ||
| WO-2025081139-A1 | Hydrogel compositions for treatment of malignant gliomas | Inactive | 12-Oct-2023 | A61K38/2086 |
Targepeutics Signals
Targepeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yuvaan Tiwari Foundation | Not-For-Profit Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| National Cancer Institute | Government |
Targepeutics FAQs
-
When was Targepeutics founded?
Targepeutics was founded in 1997.
-
Where is Targepeutics headquartered?
Targepeutics is headquartered in Hummelstown, PA.
-
What is the size of Targepeutics?
Targepeutics has 5 total employees.
-
What industry is Targepeutics in?
Targepeutics’s primary industry is Drug Discovery.
-
Is Targepeutics a private or public company?
Targepeutics is a Private company.
-
What is Targepeutics’s current revenue?
The current revenue for Targepeutics is .
-
Who are Targepeutics’s investors?
Yuvaan Tiwari Foundation, National Institutes of Health, and National Cancer Institute have invested in Targepeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process